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 E D I T O R I A L  
 A  journal for the modern era 
 
 We live in a time of “now,” when we can pretty much find anything 
we need at the click of a button, have it delivered to our door within 
hours, and often without the need to compromise on quality. The mar-
ket place is more competitive than ever – as a supplier, if you can ’ t 
deliver a quality product in a timely manner, then somebody else will 
step into the gap and, before you know it, the opportunity has closed. 
 Just like every other aspect of modern life, endocrinology, diabe-
tes and metabolism are fast moving with new, often ground- breaking, 
developments emerging every week, if not every day. Technological 
advances mean that many basic scientific and clinical questions can 
now be addressed in a way that could only have been dreamt about 
as recently as five years ago. However, identifying which are the im-
portant questions to ask, and working out how best to address these, 
remains as big a challenge as ever. 
 So, when we complete a piece of work, irrespective of whether 
the findings are “positive” or “negative,” we quite rightly want to get 
our message out and into the public domain – but then the next chal-
lenge appears – how best to do this? For most of us, publishing in 
scientific journals remains important – yes, there are alternative ways 
to “publish” our findings, especially if we are sufficiently adept to ex-
ploit the opportunities presented by social media – but, at the end 
of the day, the traditional model, whereby our work is subjected to 
pre- publication scrutiny by our peers (who can hopefully point out the 
highlights, as well as the potential shortcomings!), remains as import-
ant as ever. Indeed, good peer review often adds to the quality of the 
final product – who hasn ’ t been grateful for the insightful comments 
of a reviewer or editor that have improved the quality of an article, and 
for which we can take the credit! 
 However, publishing in scientific journals remains as competitive 
as ever, with researchers aspiring to see their labours rewarded with 
acceptance by one of the “higher ranked” journals. Of course, such 
an approach is not without its challenges. The acceptance rates in 
many journals remain relatively low – and often this isn ’ t simply a re-
flection of the quality of the material submitted, but rather a “lack of 
space” such that many worthy articles are turned away, especially if 
they are not deemed sufficiently novel or are viewed as simply con-
firming the work of others. However, this strategy is flawed because 
good quality confirmatory papers, or indeed studies that refute the 
findings of previous manuscripts, may be just as important as the 
original work. Indeed, the topic of reproducibility of medical scien-
tific discovery is currently a “live debate” as public and other funding 
bodies seek to ensure they are securing full value for money from 
their investments. 
 Another issue facing the modern researcher is how to navigate the 
challenge of Open Access – again many funding bodies and host insti-
tutions demand that their grant holders/employees make their work 
available as soon as possible using the Open Access model. 
 So, when approached by Wiley to consider the introduction of a 
new journal, into what already seems a congested market place, the 
most important question to ask was whether the model proposed 
would create a journal that could meet the demands of publishing in 
the modern era. I ’ m pleased to say that Endocrinology, Diabetes & 
Metabolism has been designed to be just that. Like other journals, ul-
timately the quality of material submitted will be the key factor in de-
ciding whether an article is accepted for publication – so, for a primary 
data manuscript the validity of the hypothesis/aims, methods, results 
and discussion will all remain central to journal decision making, and 
similarly for reviews and other articles, quality will be the key watch-
word. However, while novelty will still remain important, it will not be 
an essential requirement for publication in the journal. 
 Endocrinology, Diabetes & Metabolism will accept manuscripts 
from across the full breadth of our specialty, ranging from basic sci-
ence to clinical practice, and in so doing will hopefully offer something 
for everyone. 
 As an Open Access journal one of our priorities will be to ensure 
timely publication in a manner that allows authors to readily meet their 
obligations to funding bodies and host institutions. 
 Finally, although the on- line environment offers the option to “do 
away” with word and figure limits, the Editorial Team believes strongly 
that the ability to distil a message into a compact format remains an 
essential skill and one that benefits all – in the modern world everyone 
is busy, our attention spans limited, and so delivering our message rap-
idly, in a readily digestible format, is likely to pay significant dividends 
all round. 
 Mark  Gurnell ,  Editor-in-Chief  
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